Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein

Britta Stordal; Marion Hamon; Victoria McEneaney; Sandra Roche; Jean-Pierre Gillet; John J. O’Leary; Michael Gottesman; Martin Clynes

doi:10.1371/journal.pone.0040717

Loading metrics

Open Access

Peer-reviewed

Research Article

Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein

Britta Stordal ,

* E-mail: stordalb@tcd.ie

Affiliations National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland, Department of Histopathology, St James’ Hospital and Trinity College Dublin, Dublin, Ireland
⨯
Marion Hamon,

Affiliation National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland
⨯
Victoria McEneaney,

Affiliation Department of Histopathology, St James’ Hospital and Trinity College Dublin, Dublin, Ireland
⨯
Sandra Roche,

Affiliation National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland
⨯
Jean-Pierre Gillet,

Affiliation Laboratory of Cell Biology, National Cancer Institute, National Institute of Health, Bethesda, Maryland, United States of America
⨯
John J. O’Leary,

Affiliation Department of Histopathology, St James’ Hospital and Trinity College Dublin, Dublin, Ireland
⨯
Michael Gottesman,

Affiliation Laboratory of Cell Biology, National Cancer Institute, National Institute of Health, Bethesda, Maryland, United States of America
⨯
Martin Clynes

Affiliation National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland
⨯

Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein

Britta Stordal,
Marion Hamon,
Victoria McEneaney,
Sandra Roche,
Jean-Pierre Gillet,
John J. O’Leary,
Michael Gottesman,
Martin Clynes

Published: July 11, 2012
https://doi.org/10.1371/journal.pone.0040717

Reader Comments

Post a new comment on this article

Media Coverage of This Article

Posted by PLOS_ONE_Group on 27 Jul 2012 at 22:34 GMT

The following articles represent some of the media coverage that has occurred for this paper:

Publication: Health Canal
Title: “Health News - Researchers Investigate Drug Resistant Ovarian Cancer to Improve Clinical Treatment”
http://www.healthcanal.co...

Publication: News Medical
Title: “Study investigates molecular markers in drug-resistant ovarian cancer”
http://www.news-medical.n...

Publication: thejournal.ie
Title: “TCD study aiming to improve personalisation of ovarian cancer treatment”
http://www.thejournal.ie/...

If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.

Competing interests declared: PLOS ONE Staff

RE: Media Coverage of This Article

bstordal replied to PLOS_ONE_Group on 28 Jul 2012 at 08:43 GMT

Publication: medicalindependent.ie
Title: "Trinity investigates drug resistant ovarian cancer"
http://www.medicalindepen...

Competing interests declared: Author of Manuscript

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Platinum
Is the Subject Area "Platinum" applicable to this article?

Thanks for your feedback.
Glutathione
Is the Subject Area "Glutathione" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Ovarian cancer
Is the Subject Area "Ovarian cancer" applicable to this article?

Thanks for your feedback.
Protein expression
Is the Subject Area "Protein expression" applicable to this article?

Thanks for your feedback.
P-glycoproteins
Is the Subject Area "P-glycoproteins" applicable to this article?

Thanks for your feedback.
Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.
Genetic causes of cancer
Is the Subject Area "Genetic causes of cancer" applicable to this article?

Thanks for your feedback.

Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein

Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein

Reader Comments

Post Your Discussion Comment

Why should this posting be reviewed?

Thank You!

Media Coverage of This Article

Posted by PLOS_ONE_Group on 27 Jul 2012 at 22:34 GMT

RE: Media Coverage of This Article

bstordal replied to PLOS_ONE_Group on 28 Jul 2012 at 08:43 GMT